Reductive activation of mitomycin C by neuronal nitric oxide synthase

Biochemical Pharmacology

Volumn 60, Issue 4, 2000, Pages 571-579

  Jiang, Hou Bo ^a   Ichikawa, Minoru ^b   Furukawa, Aizo ^a   Tomita, Shuhei ^a   Ichikawa, Yoshiyuki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Antitumor activity; Metabolic activation; Mitomycin C; Neuronal nitric oxide synthase; Reduction

Indexed keywords

CALMODULIN; CATALASE; MITOMYCIN C; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; POTASSIUM CYANIDE; PYRIDINE DERIVATIVE;

ARTICLE; COMPETITIVE INHIBITION; DRUG METABOLISM; ELECTRON TRANSPORT; ENZYME INHIBITION; METABOLIC ACTIVATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REDUCTION;

ALKYLATION; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; ESCHERICHIA COLI; HYDROGEN-ION CONCENTRATION; MICE; MITOMYCIN; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PYRIDINES;

EID: 0034664210     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00346-4     Document Type: Article

References (43)

1. Cummings J., Spanswick V.J., Tomasz M., Smyth J.F. Enzymology of mitomycin C metabolic activation in tumour tissue. Biochem Pharmacol. 56:1998;405-414.
2. Sartorelli A.C., Hodnick W.F., Belcourt M.F., Tomasz M., Haffty B., Fisher J.J., Rockwell S. Mitomycin C A prototype bioreductive agent . Oncol Res. 6:1994;501-508.
3. Pan S., Andrews P.A., Glover C.J., Bachur N.R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem. 259:1984;959-966.
4. Keyes S.R., Fracasso P.M., Heimbrook D.C., Rockwell S., Sligar S.G., Sartorelli A.C. Role of NADPH, cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res. 44:1984;5638-5643.
5. Tomasz M., Chowdary D., Lipman R., Shimotakahara S., Veiro D., Walker V., Verdine G.L. Reaction of DNA with chemically or enzymatically activated mitomycin C Isolation and structure of the major covalent adduct . Proc Natl Acad Sci USA. 83:1986;6702-6706.
6. 5 reductase. Cancer Res. 53:1993;4907-4912.
7. Gustafson D.L., Pritsos C.A. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J Natl Cancer Inst. 84:1992;1180-1185.
8. Gustafson D.L., Pritsos C.A. Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and anaerobic conditions. Cancer Res. 53:1993;5470-5474.
9. Siegel D., Gibson N.W., Preusch P.C., Ross D. Metabolism of mitomycin C by DT-diaphorase Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells . Cancer Res. 50:1990;7483-7489.
10. Kennedy K.A., Rockwell S., Sartorelli A.C. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res. 40:1980;2356-2360.
11. Nishiyama M., Saeki S., Aogi K., Hirabayashi N., Toge T. Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells Differences in in vitro and in vivo systems . Int J Cancer. 53:1993;1013-1016.
12. Ross D, Beall HD, Siegel D, Traver RD and Gustafson DL, Enzymology of bioreductive drug activation. Br J Cancer 74 (Suppl XXVII):: S1-S8, 1996.
13. Joseph P., Xu Y., Jaiswal A.K. Non-enzymatic and enzymatic activation of mitomycin C Identification of a unique cytosolic activity . Int J Cancer. 65:1996;263-267.
14. Spanswick V.J., Cummings J., Smyth J.F. Enzymology of mitomycin C metabolic activation in tumor tissue Characterization of a novel mitochondrial reductase . Biochem Pharmacol. 51:1996;1623-1630.
15. Marletta M.A. Nitric oxide synthase structure and mechanism. J Biol Chem. 268:1993;12231-12234.
16. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
17. Pollock JS, Nakane M, Buttery LK, Martinez A, Springall D, Polak JM, Forstermann U and Murad F, Characterization of and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265: C1379-C1387, 1993.
18. Forstermann U., Gath I., Schwarz P., Closs E.I., Kleinert H. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol. 50:1995;1321-1332.
19. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
20. Sheta E.A., McMillan K., Masters B.S.S. Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase. J Biol Chem. 269:1994;15147-15153.
21. Abu-Soud H.M., Yoho L.L., Stuehr D.J. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. Activation of intra- and interdomain electron transfer. J Biol Chem. 269:1994;32047-32050.
22. Forstmann U., Gorsky L.D., Pollock J.S., Ishii K., Schmidt H.H.H.W., Heller M., Murad F. Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol. 38:1990;7-13.
23. Jenkins D.C., Charles I.G., Baylis S.A., Lelchuk R., Radomski M.W., Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase expression and nitric oxide generation. Br J Cancer. 70:1994;847-849.
24. 2+/calmodulin-dependent nitric oxide synthase activity in the human cervix carcinoma cell line ME-180. Biochem J. 289:1993;357-361.
25. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55:1995;727-730.
26. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., Harris C.C. Frequent nitric oxide synthase-2 expression in human colon adenomas Implication for tumor angiogenesis and colon cancer progression . Cancer Res. 58:1998;334-341.
27. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer. 72:1995;41-44.
28. Thomsen L.L., Sargent J.M., Williamson C.J., Elgie A.W. Nitric oxide synthase activity in fresh cells from ovarian tumour tissue Relationship of enzyme activity with clinical parameters of patients with ovarian cancer . Biochem Pharmacol. 56:1998;1365-1370.
29. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J Biol Chem. 267:1992;11374-11378.
30. Jiang H.B., Ichikawa Y. Neuronal nitric oxide synthase catalyzes the reduction of 7-ethoxyresorufin. Life Sci. 65:1999;1257-1261.
31. Ogura T., Yokoyama T., Fujisawa H., Kurashima Y., Esumi H. Structural diversity of neuronal nitric oxide synthase mRNA in the nervous system. Biochem Biophys Res Commun. 193:1993;1014-1022.
32. Feelisch M., Noack E.A. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur J Pharmacol. 139:1987;19-30.
33. Baek K.J., Thiel B.A., Lucas S., Stuehr D.J. Macrophage nitric oxide synthase subunits. J Biol Chem. 268:1993;21120-21129.
34. 5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells. J Biol Chem. 273:1998;8875-8881.
35. McMillan K., Masters B.S.S. Prokaryotic expression of the heme- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides Identification of the heme-binding proximal thiolate ligand as cysteine-415 . Biochemistry. 34:1995;3686-3693.
36. Pou S., Pou W.S., Bredt D.S., Snyder S.H., Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem. 267:1992;24173-24176.
37. Hoey B.M., Butler J., Swallow A.J. Reductive activation of mitomycin C. Biochemistry. 27:1988;2608-2614.
38. Moore H.W. Bioactivation as a model for drug design bioreductive alkylation. Science. 197:1977;527-532.
39. Suresh Kumar G., Lipman R., Cummings J., Tomasz M. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C. Biochemistry. 36:1997;14128-14136.
40. Gorren A.C.F., Schrammel A., Schmidt K., Mayer B. Effects of pH on the structure and function of neuronal nitric oxide synthase. Biochem J. 331:1998;801-807.
41. Tomasz M., Lipman R. Alkylation reactions of mitomycin C at acid pH. J Am Chem Soc. 101:1979;6063-6067.
42. Ambs S., Merriam W.G., Ogunfusika M.O., Bennett W.P., Ishibe N., Hussain S.P., Tzeng E.E., Geller D.A., Billiar T.R., Harris C.C. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med. 4:1998;1371-1376.
43. Spanswick V.J., Cummings J., Ritchie A.A., Smyth J.F. Pharmacological determinants of the antitumour activity of mitomycin C. Biochem Pharmacol. 56:1998;1497-1503.